StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Ajanta Pharma Limited
NSE:AJANTPHARM.NS
Sector
Location
Market Cap
USD 3.88 B
Share Price
USD 30.75
Avg Daily Volume
115,497
Change (1 day)
-0.06%
Change (1 year)
14.57%
Change (YTD)
-10.22%
Ajanta Pharma Limited EBITDA for the year ending March 31, 2025: USD 148.42 M
Ajanta Pharma Limited EBITDA is USD 148.42 M for the year ending March 31, 2025, a -1.48% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
Ajanta Pharma Limited EBITDA for the year ending March 31, 2024 was USD 150.65 M, a 40.48% change year over year.
-
Ajanta Pharma Limited EBITDA for the year ending March 31, 2023 was USD 107.24 M, a -22.04% change year over year.
-
Ajanta Pharma Limited EBITDA for the year ending March 31, 2022 was USD 137.56 M, a -1.64% change year over year.
-
Ajanta Pharma Limited EBITDA for the year ending March 31, 2021 was USD 139.85 M, a 36.68% change year over year.
Competitors
Johnson & Johnson
USD 156.82
JNJ
-0.08
-0.05%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
Haleon plc
USD 4.93
HLN.L
-0.02
-0.48%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 27.58
600436.SS
-0.04
-0.13%
Yunnan Baiyao Group Co.,Ltd
USD 7.81
000538.SZ
-0.01
-0.16%
Nahdi Medical Company
USD 34.66
4164.SR
+0.27
0.77%
Rohto Pharmaceutical Co.,Ltd.
USD 13.91
4527.T
-0.08
-0.58%
Jamjoom Pharmaceuticals Factory Company
USD 47.84
4015.SR
+1.20
2.58%
Gerresheimer AG
USD 57.83
GXI.DE
+0.53
0.93%
Zhejiang CONBA Pharmaceutical Co.,Ltd.
USD 0.63
600572.SS
+0.00
0.20%
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
Johnson & Johnson
USD 156.82
JNJ
-0.08
-0.05%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
Haleon plc
USD 4.93
HLN.L
-0.02
-0.48%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 27.58
600436.SS
-0.04
-0.13%
Yunnan Baiyao Group Co.,Ltd
USD 7.81
000538.SZ
-0.01
-0.16%
Nahdi Medical Company
USD 34.66
4164.SR
+0.27
0.77%
Rohto Pharmaceutical Co.,Ltd.
USD 13.91
4527.T
-0.08
-0.58%
Jamjoom Pharmaceuticals Factory Company
USD 47.84
4015.SR
+1.20
2.58%
Gerresheimer AG
USD 57.83
GXI.DE
+0.53
0.93%
Zhejiang CONBA Pharmaceutical Co.,Ltd.
USD 0.63
600572.SS
+0.00
0.20%
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%